Gensaic
PrivateLast Round
Collaboration Agreement
Mar 3, 2025
Total Funding Raised
$3.5M
Company Overview
Gensaic operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Grant round in January 2023.
Gensaic is a biotechnology company that has developed a machine-guided protein design platform to create tissue-selective, intracellular therapies for metabolic and age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gensaic Comparables
Compare Gensaic with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Senda Biosciences | 81% | |
| Sail Biomedicines | 78% | |
| Entos Pharmaceuticals | 78% |
For institutional investors. Book with your work email.
Gensaic Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Collaboration Agreement | Mar 3, 2025 | ||||
| Grant | Jan 9, 2023 | ||||
| VC Round | Aug 24, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Gensaic Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cystic Fibrosis Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Grew 23% QoQ, from 13 to 16 employees.
- Mar 3, 2025
Secured a Collaboration Agreement round of funding.
For institutional investors. Book with your work email.
Gensaic Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gensaic's valuation, stock price, and market status.
Is Gensaic a public or private company?
Gensaic is a private company.
What is the current stock price of Gensaic?
Gensaic is a private company, so its shares have no public market price. Caplight tracks Gensaic's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gensaic worth (valuation)?
Valuation information for Gensaic is not publicly available.
Can I buy Gensaic stock?
Gensaic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gensaic's last funding round?
Gensaic's most recent funding round was Collaboration Agreement on March 3, 2025.
Who are the main investors in Gensaic?
Key investors in Gensaic include Cystic Fibrosis Foundation.
Will Gensaic IPO soon?
No public IPO plans have been announced for Gensaic.
How can I track Gensaic secondary market activity?
Caplight tracks bids, offers, and trades in Gensaic's shares on secondary markets.